Physician-led wellness brand brings its evidence-based longevity and recovery model to downtown LA. LOS ANGELES, CA / ACCESS ...

Novo Nordisk has topped Pfizer’s offer for Metsera with a bid of up to US$9 billion, seeking to secure Metsera’s obesity-drug ...

Regeneron and ModeX Therapeutics have joined forces in a collaboration worth over one billion dollars to develop ...

In an era where chronic inflammatory diseases are taking centre stage in healthcare debates, the biologics segment is ...

Novartis will acquire Avidity Biosciences for about US$12 billion to gain its RNA platform and late-stage rare-disease ...

MESA, ARIZONA / ACCESS Newswire / October 30, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), a diversified holding company operating at the intersection of technology, wellness, and ...

AGFA HealthCare will highlight what truly drives transformation in medical imaging: clinicians. CARLSTADT, NEW JERSEY / ACCESS Newswire / October 30, 2025 / While technology enables progress, AGFA ...

NEW YORK, NY / ACCESS Newswire / October 30, 2025 / In the face of growing global concern over the potential use of chemical weapons such as the nerve agent Sarin, Lunai Bioworks Inc. (NASDAQ:LNAI) ...

BOCA RATON, FL / ACCESS Newswire / October 30, 2025 / Entero Therapeutics (NASDAQ:ENTO) has just made one of the boldest moves in its history, a reinvention that trades long biotech timelines for ...

Boehringer Ingelheim licences a novel small-molecule treatment from Kyowa Kirin for fibro-inflammatory and autoimmune diseases in a deal worth up to €410 million.

CNX Therapeutics, a specialty pharmaceutical company, has been recognised with two prestigious industry awards during CPHI week in Frankfurt, marking three awards in two months for the London-based ...

The global digital health market is set to witness a significant growth rate of 20-25% in the next 5 years. increasing adoption of smartphones and wearable devices, rising demand for remote healthcare ...